scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Amany Zekry | Q56968084 |
Geoffrey W McCaughan | Q93355454 | ||
P2860 | cites work | Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. | Q43037625 |
A longitudinal analysis of hepatitis C virus replication following liver transplantation | Q43047520 | ||
Features of the CD4+ T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels | Q43897811 | ||
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation | Q44654522 | ||
Host genetic factors influence disease progression in chronic hepatitis C. | Q45191664 | ||
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. | Q45765597 | ||
Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis | Q45853314 | ||
Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis | Q27478238 | ||
Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 | ||
Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection | Q29620141 | ||
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C | Q29620614 | ||
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C | Q29620791 | ||
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response | Q29620891 | ||
Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation | Q30468172 | ||
Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection | Q34294938 | ||
Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection | Q35358973 | ||
Reinfection of liver graft by hepatitis C virus after liver transplantation | Q35601328 | ||
Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. | Q38490006 | ||
Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus | Q38497824 | ||
Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines | Q38506378 | ||
Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. | Q38507365 | ||
Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease | Q40819259 | ||
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection | Q40836214 | ||
The role of immune responses in the pathogenesis of hepatitis C virus infection | Q41681577 | ||
Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation | Q41704164 | ||
HCV-related fibrosis progression following liver transplantation: increase in recent years | Q41732518 | ||
The association between hepatitis C infection and survival after orthotopic liver transplantation | Q42672810 | ||
Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. | Q42980400 | ||
Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels | Q42986489 | ||
Cholestatic hepatitis C in liver allografts | Q42988835 | ||
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. | Q42997954 | ||
Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study | Q42998125 | ||
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma | Q42999955 | ||
Involvement of the fas system in hepatitis C virus recurrence after liver transplantation. | Q43000157 | ||
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation | Q43000722 | ||
Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C. | Q43001097 | ||
High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome | Q43029670 | ||
Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages | Q43036009 | ||
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver | Q43036220 | ||
Hepatitis C virus kinetics during and immediately after liver transplantation. | Q43036834 | ||
P433 | issue | 10 Suppl 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Hepatitis C virus | Q708693 |
hepatitis C | Q154869 | ||
P304 | page(s) | S7-S13 | |
P577 | publication date | 2002-10-01 | |
P1433 | published in | Liver Transplantation | Q15730498 |
P1476 | title | Pathogenesis of hepatitis C virus recurrence in the liver allograft | |
P478 | volume | 8 |
Q27011871 | Challenges of recurrent hepatitis C in the liver transplant patient |
Q27485293 | Effect of Cell Polarization on Hepatitis C Virus Entry |
Q38011694 | Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants |
Q35621603 | Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation |
Q43241172 | Hepatic lipid peroxidation and antioxidant micronutrients in hepatitis virus C liver recipients with and without disease recurrence. |
Q37777154 | Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression. |
Q44353697 | Hepatitis C virus-associated cholestatic hepatitis: we cannot seem to agree on diagnostic criteria |
Q37654458 | Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review |
Q35769705 | Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. |
Q26782017 | Impact of new treatment options for hepatitis C virus infection in liver transplantation |
Q79117983 | Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors |
Q42460742 | Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance |
Q43040672 | Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation. |
Q37352203 | Primary hepatocytes as targets for hepatitis C virus replication |
Q35572080 | Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation |
Q35210857 | Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation |
Q40458556 | Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation. |
Q34280934 | Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis |
Q45381807 | Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation. |
Q35835125 | Should patients with chronic hepatitis C infection be transplanted? |
Q53096107 | Systematic investigation of elevated transaminases during the third posttransplant month. |
Q53237682 | The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients. |
Search more.